Fulvestrant (F)+Placebo vs F+Palbociclib First Line for Postmenopausal Hormone Receptor+ Advanced Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Neoplasms
Interventions: DRUG: PD-0332991 (Palbociclib)|DRUG: Fulvestrant|DRUG: Placebo
Sponsor: Spanish Breast Cancer Research Group
Collaborators: AstraZeneca